Shan Jiang
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Minzu University of China(CN)Jinan University(CN)Shanxi Medical University(CN)Yangtze University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Peking Union Medical College Hospital(CN)University of Oxford(GB)Hunan Cancer Hospital(CN)Peking University People's Hospital(CN)Second Hospital of Shanxi Medical University(CN)Jining First People's Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)Changchun University(CN)Hubei University(CN)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, melanin and skin pigmentation, Cancer, Stress, Anesthesia, and Immune Response, Gut microbiota and health, Tryptophan and brain disorders
Most-Cited Works
- → Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice(2010)823 cited
- → Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer(2014)722 cited
- → TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma(2012)560 cited
- → SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression(2011)525 cited
- → Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer(2019)211 cited
- → mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization(2008)203 cited